INVO Bioscience Inc (INVO) plunged -4.97 in the last month: It’s impossible to believe the numbers

INVO Bioscience Inc (NASDAQ: INVO) kicked off on November 20, 2023, at the price of $1.72, down -4.97% from the previous trading day. During the day, the shares moved up to $1.91 and dropped to $1.71 before settling in for the closing price of $1.81. Over the past 52 weeks, INVO has traded in a range of $0.50-$24.79.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Annual sales at Healthcare sector company grew by 93.11% over the past five years. While this was happening, its average annual earnings per share was recorded 66.28%. With a float of $2.45 million, this company’s outstanding shares have now reached $2.47 million.

Let’s look at the performance matrix of the company that is accounted for 15 employees. In terms of profitability, gross margin is +27.85, operating margin of -1292.45, and the pretax margin is -1324.46.

INVO Bioscience Inc (INVO) Insider Updates

Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of INVO Bioscience Inc is 0.94%, while institutional ownership is 12.88%.

INVO Bioscience Inc (INVO) Performance Highlights and Predictions

In the latest quarterly report, which was put into the public domain on 12/30/2022, the organization reported -$0.23 earnings per share (EPS), lower than consensus estimate (set at -$0.19) by -$0.04. This company achieved a net margin of -1324.81 while generating a return on equity of -343.99. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 66.28% per share during the next fiscal year.

INVO Bioscience Inc (NASDAQ: INVO) Trading Performance Indicators

Take a look at INVO Bioscience Inc’s (INVO) current performance indicators. Last quarter, stock had a quick ratio of 0.31. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.21.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.41, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -0.29 in one year’s time.

Technical Analysis of INVO Bioscience Inc (INVO)

INVO Bioscience Inc (NASDAQ: INVO) saw its 5-day average volume 5.83 million, a positive change from its year-to-date volume of 1.16 million. As of the previous 9 days, the stock’s Stochastic %D was 64.31%. Additionally, its Average True Range was 0.38.

During the past 100 days, INVO Bioscience Inc’s (INVO) raw stochastic average was set at 18.21%, which indicates a significant decrease from 59.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 355.56% in the past 14 days, which was higher than the 294.23% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.0837, while its 200-day Moving Average is $5.4209. Nevertheless, the first resistance level for the watch stands at $1.8500 in the near term. At $1.9800, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0500. If the price goes on to break the first support level at $1.6500, it is likely to go to the next support level at $1.5800. Assuming the price breaks the second support level, the third support level stands at $1.4500.

INVO Bioscience Inc (NASDAQ: INVO) Key Stats

The company with the Market Capitalisation of 4.25 million has total of 2,450K Shares Outstanding. Its annual sales at the moment are 820 K in contrast with the sum of -10,890 K annual income. Company’s last quarter sales were recorded 320 K and last quarter income was -2,240 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Iris Energy Ltd (IREN) ticks all the boxes for top investors with its surprise performance of 24.18% last month.

Iris Energy Ltd (NASDAQ: IREN) on November 27, 2023, started off the session at the price of $3.48, soaring 7.34% from the previous trading...

EQT Corp (EQT) last year’s performance of -7.64% is a clear signal for an entertaining trading season.

November 27, 2023, EQT Corp (NYSE: EQT) trading session started at the price of $40.51, that was -1.52% drop from the session before. During...

Oracle Corp. (ORCL) is ready for next Episode as it posted an annual sales of 49,954 M

On November 27, 2023, Oracle Corp. (NYSE: ORCL) opened at $116.005, higher 0.19% from the last session. During the day, the shares moved up...


Please enter your comment!
Please enter your name here